| 000 | 01649 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514201740.0 | ||
| 264 | 0 | _c20041209 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a0732-8893 | ||
| 024 | 7 |
_a10.1016/j.diagmicrobio.2004.05.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUmeh, Obiamiwe Chukwudiebere | |
| 245 | 0 | 0 |
_aCorynebacterium jeikeium sepsis after 8-methoxypsolaren photopheresis for cutaneous T-cell lymphoma. _h[electronic resource] |
| 260 |
_bDiagnostic microbiology and infectious disease _cSep 2004 |
||
| 300 |
_a71-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBacteremia _xdiagnosis |
| 650 | 0 | 4 |
_aCorynebacterium _xclassification |
| 650 | 0 | 4 |
_aCorynebacterium Infections _xdiagnosis |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aLymphoma, T-Cell, Cutaneous _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethoxsalen _xtherapeutic use |
| 650 | 0 | 4 |
_aOpportunistic Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPhotopheresis _xmethods |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVancomycin _xadministration & dosage |
| 700 | 1 | _aKubak, Bernard Michael | |
| 700 | 1 | _aPegues, David Alexander | |
| 700 | 1 | _aLeibowitz, Matthew Richard | |
| 700 | 1 | _aFroch, Larry | |
| 773 | 0 |
_tDiagnostic microbiology and infectious disease _gvol. 50 _gno. 1 _gp. 71-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.diagmicrobio.2004.05.001 _zAvailable from publisher's website |
| 999 |
_c15073524 _d15073524 |
||